WO2015058175A3 - Detecting and monitoring mutations in histiocytosis - Google Patents
Detecting and monitoring mutations in histiocytosis Download PDFInfo
- Publication number
- WO2015058175A3 WO2015058175A3 PCT/US2014/061281 US2014061281W WO2015058175A3 WO 2015058175 A3 WO2015058175 A3 WO 2015058175A3 US 2014061281 W US2014061281 W US 2014061281W WO 2015058175 A3 WO2015058175 A3 WO 2015058175A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- histiocytosis
- detecting
- mutations
- monitoring
- patient
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Provided is methods of detecting a mutation in a histiocytosis patient. Also provided is methods of selecting and/or applying treatment or therapy for a histiocytosis patient. Further provided is a method of treating a patient having a histiocytosis.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14853756.6A EP3058103A4 (en) | 2013-10-19 | 2014-10-18 | Detecting and monitoring mutations in histiocytosis |
IL244733A IL244733A0 (en) | 2013-10-19 | 2016-03-22 | Detecting and monitoring mutations in histiocytosis |
HK16110254.2A HK1222206A1 (en) | 2013-10-19 | 2016-08-29 | Detecting and monitoring mutations in histiocytosis |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361893218P | 2013-10-19 | 2013-10-19 | |
US61/893,218 | 2013-10-19 | ||
US201461977611P | 2014-04-09 | 2014-04-09 | |
US61/977,611 | 2014-04-09 | ||
US201462006261P | 2014-06-01 | 2014-06-01 | |
US62/006,261 | 2014-06-01 | ||
US201462040366P | 2014-08-21 | 2014-08-21 | |
US62/040,366 | 2014-08-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2015058175A2 WO2015058175A2 (en) | 2015-04-23 |
WO2015058175A3 true WO2015058175A3 (en) | 2015-06-25 |
Family
ID=52828866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2014/061281 WO2015058175A2 (en) | 2013-10-19 | 2014-10-18 | Detecting and monitoring mutations in histiocytosis |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3058103A4 (en) |
HK (1) | HK1222206A1 (en) |
IL (1) | IL244733A0 (en) |
WO (1) | WO2015058175A2 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100285469A1 (en) * | 2007-10-10 | 2010-11-11 | Philadelphia Health & Education d/b/a Drexel University College of Medicine | Method of tumor screening |
US20130130264A1 (en) * | 2011-10-24 | 2013-05-23 | Enrico Tiacci | Methods of Detecting BRAF Mutations in Cancer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2129791A4 (en) * | 2007-02-26 | 2010-07-28 | Wayne John Cancer Inst | Utility of b-raf dna mutation in diagnosis and treatment of cancer |
-
2014
- 2014-10-18 WO PCT/US2014/061281 patent/WO2015058175A2/en active Application Filing
- 2014-10-18 EP EP14853756.6A patent/EP3058103A4/en not_active Withdrawn
-
2016
- 2016-03-22 IL IL244733A patent/IL244733A0/en unknown
- 2016-08-29 HK HK16110254.2A patent/HK1222206A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100285469A1 (en) * | 2007-10-10 | 2010-11-11 | Philadelphia Health & Education d/b/a Drexel University College of Medicine | Method of tumor screening |
US20130130264A1 (en) * | 2011-10-24 | 2013-05-23 | Enrico Tiacci | Methods of Detecting BRAF Mutations in Cancer |
Non-Patent Citations (1)
Title |
---|
BADALIAN ET AL.: "Recurrent BRAF mutations in Langerhans cell histiocytosis", BLOOD, vol. 116, no. 11, 16 September 2010 (2010-09-16), pages 1919 - 1923, XP055027891 * |
Also Published As
Publication number | Publication date |
---|---|
EP3058103A4 (en) | 2017-05-17 |
WO2015058175A2 (en) | 2015-04-23 |
HK1222206A1 (en) | 2017-06-23 |
EP3058103A2 (en) | 2016-08-24 |
IL244733A0 (en) | 2016-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3369491A4 (en) | Environmentally-friendly medical waste treatment apparatus and method specific to medical institutions | |
EP3157620A4 (en) | Method and apparatus for neuromodulation treatments of pain and other conditions | |
ZA201802351B (en) | Electrode system, device and method for the treatment of eye diseases, in particular dry eye | |
EP3367986A4 (en) | Tissue treatment device and method | |
EP3156081A4 (en) | Cell structure for use in treatment of brain injury, method for producing same, and therapeutic agent for brain injury | |
EP3429683A4 (en) | Microcurrent device and method for the treatment of visual disease | |
EP3505091A4 (en) | Medical device and treatment method | |
EP3212274A4 (en) | Chemical ablation and method of treatment for various diseases | |
PL2996737T3 (en) | Device and method for making available treatment parameters for the treatment of a patient | |
EP3084000A4 (en) | Method of diagnosis and treatment | |
EP3013407A4 (en) | Medical treatment system and method of use | |
EP3183010A4 (en) | Devices for treating medical waste and methods of their use | |
PH12015502302A1 (en) | Treatment of allergic rhinitis using a combination of mometasone and olopatadine | |
EP3490436A4 (en) | Methods for detecting and treating pain using brain activity | |
PL2687248T3 (en) | Apparatus and method for determining a parameter indicative of the progress of an extracorporeal blood treatment | |
EP3445265A4 (en) | Skin treatment apparatus and method | |
GB2525023B (en) | Apparatus and method for treating a patient having a heart | |
EP3508148A4 (en) | Medical device and treatment method | |
EP3145573A4 (en) | Portable medical treatment system and method of use | |
EP3407961A4 (en) | Skin treatment apparatus and method | |
GB201309727D0 (en) | Water monitor/treatment apparatus and method | |
EP3520724A4 (en) | Medical device and treatment method | |
EP3427678A4 (en) | Medical device and treatment method | |
EP3012611A4 (en) | Tissue piece treating apparatus and method of operating tissue piece treating apparatus | |
ZA201802680B (en) | Process and preparation of compounds for use in the treatment of androgen deprivation therapy associated symptoms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14853756 Country of ref document: EP Kind code of ref document: A2 |
|
REEP | Request for entry into the european phase |
Ref document number: 2014853756 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2014853756 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 244733 Country of ref document: IL |
|
NENP | Non-entry into the national phase |
Ref country code: DE |